$160.71
5.963.85%
Last update: 3:11 PM
15 minutes delayed
Comments
Loading...
BeiGene
BGNENASDAQ
BeiGene (NASDAQ:BGNE) Stock, Insider Trading Activity
BeiGene: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are BeiGene Ltd Insiders Doing?
At BeiGene Ltd, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 6.68K shares worth $1.06M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On July 3, 2024, Aijun Julia Wang, the company's CHIEF FINANCIAL OFFICER sold 472 shares for $143.9 each.
- On June 20, 2024, Henry Chan Lee, the company's SVP, GENERAL COUNSEL sold 439 shares for $159.35 each.
- On June 26, 2024, Aijun Julia Wang, the company's CHIEF FINANCIAL OFFICER sold 899 shares for $155.66 each.
Ownership Statistics for BeiGene Ltd
Shares Outstanding
105.810M%
Institutional Shares Held
25.962M
Institutional Percentage Held
24.5%
| Jul 03, 2024 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -472.00 | $143.90 | -$67.92K | SELL | -0.11% | 426.60K | Jul 01 | View |
| Jun 26, 2024 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -899.00 | $155.66 | -$139.94K | SELL | -0.21% | 432.73K | Jun 24 | View |
| Jun 26, 2024 | Lai Wang | GLOBAL HEAD R&D | -1.06K | $159.80 | -$170.03K | SELL | -100.00% | 0.00 | Jun 24 | View |
| Jun 26, 2024 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -1.46K | $159.79 | -$233.13K | SELL | -100.00% | 0.00 | Jun 24 | View |
| Jun 26, 2024 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -2.79K | $159.58 | -$445.07K | SELL | -2.66% | 102.19K | Jun 24 | View |
| Jun 20, 2024 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -1.28K | $159.35 | -$204.12K | SELL | -1.24% | 102.19K | Jun 17 | View |
| Jun 20, 2024 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -916.00 | $159.04 | -$145.68K | SELL | -0.21% | 444.42K | Jun 17 | View |
| Jun 20, 2024 | Lai Wang | GLOBAL HEAD R&D | -2.34K | $157.27 | -$368.16K | SELL | -100.00% | 0.00 | Jun 17 - Jun 18 | View |
| Jun 20, 2024 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -3.25K | $155.26 | -$505.21K | SELL | -100.00% | 0.00 | Jun 17 - Jun 18 | View |
| Jun 20, 2024 | Henry Chan Lee | SVP, GENERAL COUNSEL | -439.00 | $159.35 | -$69.96K | SELL | -0.17% | 263.69K | Jun 17 | View |
| Apr 11, 2024 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -50.00K | $149.50 | -$7.48M | SELL | -32.85% | 102.19K | Apr 09 - Apr 11 | View |
| Mar 14, 2024 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -50.00K | $167.36 | -$8.37M | SELL | -32.85% | 102.19K | Mar 12 - Mar 13 | View |
| Mar 04, 2024 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -397.00 | $167.08 | -$66.33K | SELL | -0.12% | 320.09K | Feb 29 | View |
| Nov 14, 2023 | BAKER BROS ADVISORS LP LPJULIAN BAKERFELIX BAKERBaker Bros Advisors GP LLCBaker Brothers Life Sciences LP | DIRECTOR | -1.10M | $180.50 | -$198.55M | SELL | -10.18% | 9.70M | Nov 14 | View |
| Aug 02, 2023 | Henry Chan Lee | SVP, GENERAL COUNSEL | -791.00 | $216.26 | -$171.06K | SELL | -0.46% | 171.31K | Jul 31 | View |
| Jul 06, 2023 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -472.00 | $179.55 | -$84.75K | SELL | -0.14% | 325.25K | Jul 03 | View |
| Jun 27, 2023 | Lai Wang | GLOBAL HEAD R&D | -1.11K | $181.92 | -$201.57K | SELL | -100.00% | 0.00 | Jun 26 | View |
| Jun 27, 2023 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -840.00 | $182.85 | -$153.59K | SELL | -0.25% | 331.38K | Jun 23 | View |
| Jun 27, 2023 | Corsee Corazon Sanders | DIRECTOR | -578.00 | $182.32 | -$105.38K | SELL | -1.90% | 29.90K | Jun 23 | View |
| Jun 27, 2023 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -1.50K | $182.36 | -$272.64K | SELL | -100.00% | 0.00 | Jun 26 | View |
| Jun 20, 2023 | Lai Wang | GLOBAL HEAD R&D | 132.30K | $192.42 | -$254.96K | GRANT | ∞ | 0.00 | Jun 15 - Jun 20 | View |
| Jun 20, 2023 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | 107.58K | $192.54 | -$36.58K | GRANT | ∞ | 0.00 | Jun 15 - Jun 20 | View |
| Jun 20, 2023 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | 198.69K | $192.44 | -$337.36K | GRANT | ∞ | 0.00 | Jun 15 - Jun 20 | View |
| Jun 15, 2023 | HHLR ADVISORS LTDHILLHOUSE INVESTMENT MANAGEMENT LTD | 10% OWNER | -1.20M | $188.88 | -$226.31M | SELL | -0.83% | 142.89M | Jun 13 - Jun 14 | View |
| Jun 12, 2023 | HHLR ADVISORS LTDHILLHOUSE INVESTMENT MANAGEMENT LTD | 10% OWNER | -2.96M | $201.98 | -$597.18M | SELL | -2.01% | 144.09M | Jun 08 - Jun 12 | View |
| Jun 09, 2023 | Lai Wang | GLOBAL HEAD R&D | -462.00 | $224.74 | -$103.83K | SELL | -100.00% | 0.00 | Jun 07 | View |
| Jun 09, 2023 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -3.29K | $224.73 | -$739.60K | SELL | -100.00% | 0.00 | Jun 07 | View |
| May 10, 2023 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -7.00K | $253.72 | -$1.78M | SELL | -100.00% | 0.00 | May 08 | View |
| Mar 10, 2023 | Xiaodong Wang | DIRECTOR | 0.00 | $113.08 | -$15.28M | SELL-OPTIONS | 0.00% | 50.00 | Mar 08 | View |
| Mar 03, 2023 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -343.00 | $240.21 | -$82.39K | SELL | -0.14% | 237.00K | Mar 01 | View |
| Jan 17, 2023 | Xiaodong Wang | DIRECTOR | -5.00K | $260.52 | -$1.30M | SELL | -99.01% | 50.00 | Jan 12 | View |
| Jan 12, 2023 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -20.39K | $248.51 | -$5.07M | SELL | -16.63% | 102.19K | Jan 10 | View |
| Jan 11, 2023 | Xiaodong Wang | DIRECTOR | -5.00K | $251.36 | -$1.26M | SELL | -99.01% | 50.00 | Jan 09 - Jan 11 | View |
| Dec 29, 2022 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -9.61K | $224.43 | -$2.16M | SELL | -8.60% | 102.19K | Dec 27 - Dec 29 | View |
| Dec 15, 2022 | Xiaodong Wang | DIRECTOR | -3.01K | $211.33 | -$636.72K | SELL | -98.37% | 50.00 | Dec 13 | View |
| Nov 17, 2022 | Xiaodong Wang | DIRECTOR | -1.99K | $210.14 | -$417.54K | SELL | -97.55% | 50.00 | Nov 15 | View |
| Nov 17, 2022 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -29.93K | $206.84 | -$6.19M | SELL | -22.65% | 102.19K | Nov 15 | View |
| Sep 22, 2022 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -50.00K | $152.13 | -$7.61M | SELL | -32.85% | 102.19K | Sep 20 - Sep 21 | View |
| Aug 09, 2022 | Xiaodong Wang | DIRECTOR | -16.06K | $196.65 | -$3.16M | SELL | -99.69% | 50.00 | Aug 05 - Aug 08 | View |
| Jul 05, 2022 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -295.00 | $158.50 | -$46.76K | SELL | -0.12% | 241.75K | Jul 01 | View |
| Jun 28, 2022 | Lai Wang | GLOBAL HEAD R&D | -458.00 | $177.32 | -$81.21K | SELL | -100.00% | 0.00 | Jun 27 | View |
| Jun 22, 2022 | Lai Wang | GLOBAL HEAD R&D | -1.17K | $145.35 | -$169.77K | SELL | -100.00% | 0.00 | Jun 17 - Jun 21 | View |
| Jun 22, 2022 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -1.59K | $142.63 | -$226.49K | SELL | -100.00% | 0.00 | Jun 17 - Jun 21 | View |
| Jun 21, 2022 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -161.00 | $136.64 | -$22.00K | SELL | -0.11% | 141.21K | Jun 17 | View |
| Jun 08, 2022 | Lai Wang | GLOBAL HEAD R&D | -660.00 | $142.00 | -$93.72K | SELL | -100.00% | 0.00 | Jun 06 | View |
| Jun 08, 2022 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -3.41K | $141.99 | -$484.20K | SELL | -100.00% | 0.00 | Jun 06 | View |
| May 06, 2022 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -6.72K | $164.35 | -$1.11M | SELL | -62.70% | 4.00K | May 05 | View |
| Dec 16, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $199.05 | -$237.27K | SELL-OPTIONS | 0.00% | 160.06K | Dec 14 | View |
| Dec 02, 2021 | Jane Huang | CMO, HEMATOLOGY | 14.82K | $359.86 | -$377.49K | GRANT | ∞ | 0.00 | Nov 30 - Dec 01 | View |
| Nov 19, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $250.65 | -$392.06K | SELL-OPTIONS | 0.00% | 145.24K | Nov 17 | View |
| Nov 10, 2021 | Xiaodong Wang | DIRECTOR | -4.50K | $350.04 | -$1.58M | SELL | -98.90% | 50.00 | Nov 08 | View |
| Nov 10, 2021 | Xiaodong Wang | DIRECTOR | -4.50K | $349.81 | -$1.57M | SELL | -98.90% | 50.00 | Nov 08 | View |
| Nov 10, 2021 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -10.00K | $358.27 | -$3.58M | SELL | -71.43% | 4.00K | Nov 08 - Nov 09 | View |
| Oct 21, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $246.37 | -$379.22K | SELL-OPTIONS | 0.00% | 145.24K | Oct 19 | View |
| Sep 22, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $258.96 | -$1.67M | SELL-OPTIONS | 0.00% | 145.24K | Sep 20 | View |
| Sep 16, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -411.84K | $82.04 | -$33.79M | SELL | -80.12% | 102.19K | Sep 14 - Sep 15 | View |
| Sep 15, 2021 | Jane Huang | CMO, HEMATOLOGY | -12.90K | $358.14 | -$4.62M | SELL | -8.16% | 145.24K | Sep 13 | View |
| Sep 13, 2021 | AMGEN INC | 10% OWNER | 165.53K | $302.06 | $50.00M | BUY | 0.88% | 18.94M | Sep 10 | View |
| Sep 02, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -288.64K | $109.77 | -$31.69M | SELL | -73.85% | 102.19K | Aug 31 - Sep 02 | View |
| Sep 02, 2021 | Jane Huang | CMO, HEMATOLOGY | 14.29K | $318.88 | -$346.62K | GRANT | ∞ | 0.00 | Aug 31 - Sep 02 | View |
| Aug 05, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -125.31K | $132.34 | -$16.58M | SELL | -55.08% | 102.19K | Aug 04 - Aug 05 | View |
| Aug 05, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -83.36K | $182.37 | -$15.20M | SELL | -44.93% | 102.19K | Aug 03 | View |
| Jul 22, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -69.22K | $71.82 | -$4.97M | SELL | -40.38% | 102.19K | Jul 22 | View |
| Jul 22, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -70.86K | $152.13 | -$10.78M | SELL | -40.95% | 102.19K | Jul 20 - Jul 21 | View |
| Jul 19, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $239.66 | -$3.90M | SELL-OPTIONS | 0.00% | 298.66K | Jul 15 | View |
| Jul 08, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -67.48K | $94.83 | -$6.40M | SELL | -39.77% | 102.19K | Jul 07 - Jul 08 | View |
| Jul 08, 2021 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -123.82K | $117.22 | -$14.51M | SELL | -54.71% | 102.49K | Jul 06 - Jul 07 | View |
| Jul 08, 2021 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -10.18K | $325.53 | -$3.31M | SELL | -71.79% | 4.00K | Jul 06 | View |
| Jul 01, 2021 | Xiaodong Wang | DIRECTOR | -4.85K | $348.15 | -$1.69M | SELL | -98.98% | 50.00 | Jul 01 | View |
| Jul 01, 2021 | Aijun Julia Wang | CHIEF FINANCIAL OFFICER | -308.00 | $349.06 | -$107.51K | SELL | -0.38% | 79.87K | Jul 01 | View |
| Jun 30, 2021 | Jane Huang | CMO, HEMATOLOGY | -425.00 | $192.23 | -$639.09K | SELL | -0.14% | 298.66K | Jun 28 - Jun 29 | View |
| Jun 30, 2021 | Lai Wang | GLOBAL HEAD R&D | -455.00 | $362.48 | -$164.93K | SELL | -0.20% | 232.74K | Jun 28 | View |
| Jun 30, 2021 | Howard Liang | CFO & CHIEF STRATEGY OFFICER | -446.00 | $365.00 | -$162.79K | SELL | -0.03% | 1.55M | Jun 28 | View |
| Jun 21, 2021 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | 76.84K | $330.93 | -$382.55K | GRANT | ∞ | 4.00K | Jun 16 - Jun 18 | View |
| Jun 21, 2021 | Lai Wang | GLOBAL HEAD R&D | 52.82K | $331.15 | -$265.58K | GRANT | ∞ | 0.00 | Jun 16 - Jun 18 | View |
| Jun 21, 2021 | Jane Huang | CMO, HEMATOLOGY | 24.88K | $325.66 | -$152.73K | GRANT | ∞ | 0.00 | Jun 16 - Jun 18 | View |
| Jun 21, 2021 | Howard Liang | CFO & CHIEF STRATEGY OFFICER | -486.00 | $325.89 | -$158.38K | SELL | -0.03% | 1.56M | Jun 18 | View |
| Jun 11, 2021 | YungCheng Timothy Chen | DIRECTOR | 0.00 | $191.63 | -$1.92M | SELL-OPTIONS | 0.00% | 0.00 | Jun 09 - Jun 10 | View |
| Jun 09, 2021 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -3.40K | $352.54 | -$1.20M | SELL | -45.93% | 4.00K | Jun 07 | View |
| Jun 09, 2021 | Howard Liang | CFO & CHIEF STRATEGY OFFICER | -650.00 | $354.16 | -$230.20K | SELL | -0.04% | 1.57M | Jun 07 | View |
| Jun 09, 2021 | Lai Wang | GLOBAL HEAD R&D | -656.00 | $354.26 | -$232.39K | SELL | -0.33% | 195.46K | Jun 07 | View |
| Jun 09, 2021 | Jane Huang | CMO, HEMATOLOGY | -603.00 | $351.55 | -$211.99K | SELL | -0.21% | 284.93K | Jun 07 | View |
| Jun 02, 2021 | Jane Huang | CMO, HEMATOLOGY | 7.19K | $193.74 | -$686.05K | SELL-OPTIONS | ∞ | 0.00 | May 28 - Jun 01 | View |
| May 12, 2021 | Xiaodong Wang | DIRECTOR | 44.11K | $150.29 | -$1.01M | SELL-OPTIONS | ∞ | 50.00 | May 10 | View |
| May 05, 2021 | Xiaobin Wu | PRESIDENT, COO & GM CHINA | -6.71K | $343.00 | -$2.30M | SELL | -62.67% | 4.00K | May 03 | View |
| May 03, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $192.21 | -$488.15K | SELL-OPTIONS | 0.00% | 285.58K | Apr 29 | View |
| Mar 31, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $176.74 | -$441.76K | SELL-OPTIONS | 0.00% | 285.58K | Mar 29 | View |
| Mar 02, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $175.11 | -$436.86K | SELL-OPTIONS | 0.00% | 285.58K | Feb 26 | View |
| Feb 02, 2021 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $176.24 | -$440.26K | SELL-OPTIONS | 0.00% | 285.58K | Jan 29 | View |
| Jan 19, 2021 | Howard Liang | CFO & CHIEF STRATEGY OFFICER | 0.00 | $175.68 | -$4.74M | SELL-OPTIONS | 0.00% | 1.57M | Jan 14 - Jan 15 | View |
| Jan 06, 2021 | BAKER BROS ADVISORS LP LPBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERJULIAN BAKER | DIRECTOR | -121.15K | $220.50 | -$26.71M | SELL | -1.12% | 10.71M | Jan 04 | View |
| Dec 30, 2020 | Jane Huang | — | 0.00 | $139.31 | -$329.46K | OPTION EXERCISE | 0.00% | 285.58K | Dec 29 | View |
| Dec 16, 2020 | Howard Liang | — | 1.41M | $114.95 | -$19.75M | OPTION EXERCISE | ∞ | 0.00 | Dec 14 | View |
| Dec 04, 2020 | BAKER BROS ADVISORS LP LPBaker Bros Advisors GP LLCBaker Brothers Life Sciences LPFELIX BAKERJULIAN BAKER | — | -1.54M | $220.50 | -$333.30M | GIFT | -12.44% | 10.83M | Oct 13 - Dec 04 | View |
| Dec 02, 2020 | Jane Huang | — | 0.00 | $148.65 | -$357.49K | OPTION EXERCISE | 0.00% | 285.58K | Nov 30 | View |
| Nov 02, 2020 | Jane Huang | — | 0.00 | $164.78 | -$405.86K | OPTION EXERCISE | 0.00% | 285.58K | Oct 29 | View |
| Oct 20, 2020 | Xiaodong Wang | — | -5.00K | $320.00 | -$1.60M | SELL | -99.01% | 50.00 | Oct 16 | View |
| Oct 07, 2020 | Xiaodong Wang | — | -5.00K | $300.00 | -$1.50M | SELL | -99.01% | 50.00 | Oct 05 | View |
| Oct 07, 2020 | Xiaobin Wu | — | -4.00K | $300.00 | -$1.20M | SELL | -50.00% | 4.00K | Oct 05 | View |
| Oct 07, 2020 | Howard Liang | — | 0.00 | $153.05 | -$4.10M | OPTION EXERCISE | 0.00% | 168.41K | Oct 05 | View |
| Oct 01, 2020 | Jane Huang | — | 0.00 | $154.93 | -$376.33K | OPTION EXERCISE | 0.00% | 285.58K | Sep 29 | View |
| Sep 30, 2020 | JOHN OYLER | — | -54.30K | $280.39 | -$15.23M | SELL | -34.70% | 102.19K | Sep 28 - Sep 29 | View |
| Sep 29, 2020 | Xiaodong Wang | — | -5.00K | $280.42 | -$1.40M | SELL | -99.01% | 50.00 | Sep 25 | View |
| Sep 29, 2020 | Xiaobin Wu | — | -4.00K | $280.35 | -$1.12M | SELL | -50.00% | 4.00K | Sep 25 | View |
| Sep 21, 2020 | Xiaodong Wang | — | -5.00K | $260.27 | -$1.30M | SELL | -99.01% | 50.00 | Sep 17 | View |
| Sep 21, 2020 | Xiaobin Wu | — | -4.00K | $260.33 | -$1.04M | SELL | -50.00% | 4.00K | Sep 17 | View |
| Sep 16, 2020 | JOHN OYLER | — | -81.23K | $253.46 | -$20.59M | SELL | -44.29% | 102.19K | Sep 14 - Sep 16 | View |
| Sep 16, 2020 | Howard Liang | — | 0.00 | $128.38 | -$3.41M | OPTION EXERCISE | 0.00% | 168.41K | Sep 14 | View |
| Sep 08, 2020 | Jane Huang | — | -3.13K | $233.07 | -$729.05K | SELL | -1.08% | 285.58K | Sep 03 | View |
| Sep 02, 2020 | JOHN OYLER | — | -61.04K | $233.21 | -$14.24M | SELL | -37.40% | 102.19K | Aug 31 - Sep 02 | View |
| Sep 01, 2020 | Jane Huang | — | 0.00 | $135.85 | -$638.16K | OPTION EXERCISE | 0.00% | 326.25K | Aug 28 | View |
| Aug 21, 2020 | JOHN OYLER | — | -92.18K | $237.06 | -$21.85M | SELL | -47.42% | 102.19K | Aug 19 - Aug 21 | View |
| Aug 14, 2020 | JOHN OYLER | — | -42.97K | $212.71 | -$9.14M | SELL | -29.60% | 102.19K | Aug 12 - Aug 14 | View |
| Aug 12, 2020 | YungCheng Timothy Chen | — | 0.00 | $122.26 | -$1.27M | OPTION EXERCISE | 0.00% | 0.00 | Aug 10 - Aug 12 | View |
| Aug 12, 2020 | Xiaodong Wang | — | -5.56K | $211.06 | -$844.23K | GIFT | -99.11% | 50.00 | Aug 10 - Aug 11 | View |
| Aug 05, 2020 | JOHN OYLER | — | -17.25K | $223.27 | -$3.85M | SELL | -14.45% | 102.19K | Aug 05 | View |
| Aug 05, 2020 | JOHN OYLER | — | -40.56K | $221.27 | -$8.97M | SELL | -28.41% | 102.19K | Aug 03 - Aug 04 | View |
| Jul 31, 2020 | Jane Huang | — | 0.00 | $152.44 | -$344.95K | OPTION EXERCISE | 0.00% | 326.25K | Jul 29 | View |
| Jul 22, 2020 | JOHN OYLER | — | -27.75K | $238.34 | -$6.61M | SELL | -21.36% | 102.19K | Jul 22 | View |
| Jul 22, 2020 | JOHN OYLER | — | -55.17K | $251.84 | -$13.90M | SELL | -35.06% | 102.19K | Jul 20 - Jul 21 | View |
| Jul 22, 2020 | Xiaodong Wang | — | -17.00K | $251.51 | -$4.28M | SELL | -99.71% | 50.00 | Jul 20 | View |
| Jul 21, 2020 | Xiaobin Wu | — | -3.30K | $249.22 | -$822.42K | SELL | -45.21% | 4.00K | Jul 17 - Jul 20 | View |
| Jul 15, 2020 | Xiaobin Wu | — | -5.70K | $230.00 | -$1.31M | SELL | -58.76% | 4.00K | Jul 13 - Jul 15 | View |
| Jul 09, 2020 | Xiaodong Wang | — | -6.00K | $200.00 | -$1.20M | SELL | -99.17% | 50.00 | Jul 07 | View |
| Jul 09, 2020 | Jane Huang | — | 0.00 | $180.20 | -$155.27K | OPTION EXERCISE | 0.00% | 326.25K | Jul 07 | View |
| Jul 08, 2020 | JOHN OYLER | — | -53.91K | $199.12 | -$10.74M | SELL | -34.54% | 102.19K | Jul 06 - Jul 08 | View |
| Jul 06, 2020 | Xiaodong Wang | — | -4.85K | $190.75 | -$924.57K | SELL | -98.98% | 50.00 | Jul 01 | View |
| Jul 01, 2020 | JOHN OYLER | — | -5.25K | $191.85 | -$1.01M | SELL | -4.89% | 102.19K | Jun 29 - Jul 01 | View |
| Jul 01, 2020 | Howard Liang | — | -300.00 | $191.23 | -$57.37K | SELL | -0.18% | 168.41K | Jun 29 | View |
| Jun 30, 2020 | Jane Huang | — | -435.00 | $150.63 | -$407.94K | OPTION EXERCISE | -0.13% | 326.25K | Jun 26 - Jun 29 | View |
| Jun 24, 2020 | JOHN OYLER | — | -39.73K | $185.90 | -$7.39M | SELL | -28.00% | 102.19K | Jun 22 - Jun 24 | View |
| Jun 24, 2020 | Xiaodong Wang | — | -11.00K | $184.09 | -$2.02M | SELL | -99.55% | 50.00 | Jun 22 - Jun 23 | View |
| Jun 12, 2020 | JOHN OYLER | — | -900.00 | $175.07 | -$157.56K | SELL | -0.87% | 102.19K | Jun 10 | View |
| Jun 10, 2020 | Howard Liang | — | -453.00 | $170.84 | -$77.39K | SELL | -0.39% | 116.43K | Jun 08 | View |
| Jun 10, 2020 | Xiaobin Wu | — | -2.80K | $170.83 | -$478.32K | SELL | -41.18% | 4.00K | Jun 08 | View |
| Jun 10, 2020 | Jane Huang | — | -631.00 | $170.84 | -$107.80K | SELL | -0.22% | 283.46K | Jun 08 | View |
| Jun 10, 2020 | Xiaodong Wang | — | -6.00K | $170.91 | -$1.03M | SELL | -99.17% | 50.00 | Jun 08 | View |
| Jun 02, 2020 | Jane Huang | — | 0.00 | $96.67 | -$201.55K | OPTION EXERCISE | 0.00% | 291.67K | May 29 | View |
| May 21, 2020 | Donald Glazer | — | -12.68K | $169.84 | -$1.70M | GIFT | -100.00% | 0.00 | May 19 | View |
| May 05, 2020 | JOHN OYLER | — | -4.63K | $141.43 | -$655.54K | SELL | -4.34% | 102.19K | May 01 | View |
| May 05, 2020 | Xiaobin Wu | — | -7.02K | $141.33 | -$992.71K | SELL | -63.72% | 4.00K | May 01 | View |
| Apr 30, 2020 | Jane Huang | — | 0.00 | $95.90 | -$199.22K | OPTION EXERCISE | 0.00% | 291.67K | Apr 29 | View |
| Apr 17, 2020 | Jane Huang | — | 0.00 | $94.75 | -$195.76K | OPTION EXERCISE | 0.00% | 291.67K | Apr 16 | View |
| Mar 06, 2020 | Xiaodong Wang | — | -5.00K | $157.14 | -$785.68K | SELL | -99.01% | 50.00 | Mar 04 | View |
| Feb 20, 2020 | Jane Huang | — | 0.00 | $99.87 | -$211.14K | OPTION EXERCISE | 0.00% | 291.67K | Feb 18 | View |
| Jan 22, 2020 | Jane Huang | — | 0.00 | $100.09 | -$211.81K | OPTION EXERCISE | 0.00% | 291.67K | Jan 21 | View |
| Dec 19, 2019 | JOHN OYLER | CHIEF EXECUTIVE OFFICER | -62.26K | $160.62 | -$10.00M | SELL | -37.86% | 102.19K | Dec 17 | View |
| Dec 18, 2019 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $97.32 | -$203.48K | SELL-OPTIONS | 0.00% | 291.67K | Dec 16 | View |
| Nov 20, 2019 | Howard Liang | CFO & CHIEF STRATEGY OFFICER | 0.00 | $100.42 | -$4.70M | SELL-OPTIONS | 0.00% | 122.32K | Nov 18 | View |
| Nov 20, 2019 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $111.99 | -$247.51K | SELL-OPTIONS | 0.00% | 291.67K | Nov 18 | View |
| Nov 18, 2019 | Xiaodong Wang | DIRECTOR | -13.00K | $194.63 | -$2.53M | SELL | -5.48% | 224.37K | Nov 13 - Nov 15 | View |
| Nov 18, 2019 | Xiaobin Wu | PRESIDENT & GM CHINA | -1.00K | $202.05 | -$202.05K | SELL | -20.00% | 4.00K | Nov 15 | View |
| Nov 06, 2019 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $109.97 | -$5.30M | SELL-OPTIONS | 0.00% | 291.67K | Nov 04 | View |
| Nov 06, 2019 | YungCheng Timothy Chen | DIRECTOR | 0.00 | $115.43 | -$1.19M | SELL-OPTIONS | 0.00% | 0.00 | Nov 04 - Nov 05 | View |
| Nov 05, 2019 | Xiaodong Wang | DIRECTOR | -2.00K | $180.00 | -$360.00K | SELL | -0.04% | 4.95M | Nov 01 - Nov 04 | View |
| Nov 05, 2019 | Xiaobin Wu | PRESIDENT & GM CHINA | -1.00K | $180.00 | -$180.00K | SELL | -20.00% | 4.00K | Nov 01 | View |
| Sep 05, 2019 | Jane Huang | CMO, HEMATOLOGY | -2.94K | $144.03 | -$424.03K | SELL | -1.00% | 291.67K | Sep 03 - Sep 04 | View |
| Aug 27, 2019 | YungCheng Timothy Chen | DIRECTOR | -714.00 | $88.27 | -$999.12K | SELL | -100.00% | 0.00 | Aug 23 | View |
| Aug 13, 2019 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $90.03 | -$223.58K | SELL-OPTIONS | 0.00% | 328.87K | Aug 12 | View |
| Jul 31, 2019 | Jane Huang | CMO, HEMATOLOGY | 0.00 | $85.92 | -$985.06K | SELL-OPTIONS | 0.00% | 328.87K | Jul 29 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.